Navigation Links
Herceptin for Early Stage Breast cancer

Herceptin is a breast cancer drug which is approved for treatment to breast cancer patients with Her-2/neu positive gene, more than 25% of women with breast cancer// produce this Her-2 protein in their blood which makes their breast cancer very aggressive and resist chemotherapy and Tamoxifen therapy (anti-estrogen therapies). The Drug Herceptin is a humanized monoclonal antibody prepared for treating Her-2 positive patients but the drug is very costly and the Herceptin treatment is to be given for 1 year.

Herceptin is approved for late stage breast cancer treatment but a new study conducted by Breast Cancer International Research Group (BCIRG) have found that Herceptin is also very effective in treating early stage breast cancer disapproving early reports that the drug Herceptin is not effective in treating early stage breast cancer reported by The Lancet on November 10th.

Professor Dennis Slamon and his colleagues, University of California, Los Angeles, conducted a BCIRG trial and found that Herceptin supplemented with Chemotherapy in early stage breast cancer patients to Her-2/neu positive patients found better prognosis compared to chemotherapy treatment alone. The results of the trial had shown the benefits of Herceptin drug also in the treatment of early stage breast cancer.
'"/>




Page: 1

Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Drug Herceptin To Be Recommended To All Breast Cancer Patients
3. Herceptin Is A Possible Cure For Breast Cancer
4. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
5. £6000 to be refunded to Mrs. Leese for Herceptin treatmen
6. Wangaratta Community fundraising for Herceptin drug
7. Treatment of Breast Cancer with Herceptin for Nine Weeks
8. Herceptin is the cure for early stages of breast cancer?
9. 10-year-old Pleads, Herceptin For My Mum, Please
10. Norfolk PCTs To Offer Herceptin
11. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/23/2017)... ... April 23, 2017 , ... ... announced the achievement of Cisco Select certification and SMB specialization. Altura is ... , In earning the Select Certification, Altura fulfilled the training and ...
(Date:4/22/2017)... ... 22, 2017 , ... The San Juan Capistrano summer camp team at the Boys ... need for summer camps to provide physical activities for all campers. To read the report, ... Camps , With an increase in specialty camps that focus on what the report terms ...
(Date:4/21/2017)... ... , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , has ... bony lump located on the forehead usually attributed to a facial fracture. Their appearance ... Dr. Shah has discovered an approach that is minimally invasive. He is an expert ...
(Date:4/21/2017)... ... 21, 2017 , ... The adage “Show, don’t tell” applies perfectly to Green ... company’s esteemed VISION House demonstration project series. Manifesting the concept of right-sized living, the ... need to live affordably and abundantly without unduly taxing the resources of our beautiful ...
(Date:4/21/2017)... ... 21, 2017 , ... The American Medical Student Association (AMSA) ... Recovery Education, from April 24 to April 28, 2017, dedicated to increasing awareness ... The mission of AWARE is to instill a compassionate, total health approach to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Vivify Health, the pioneer ... has been awarded a very significant patent for the ... to continual care via digital health.  This landmark patent ... property and further secures Vivify,s position as the leader ... 2009, was the first company to apply consumer mobile ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
Breaking Medicine Technology: